Universitätsklinikum Hamburg-Eppendorf (UKE)

Hospital


Location: Hamburg, Germany (DE) DE

ISNI: 0000000121803484

ROR: https://ror.org/01zgy1s35

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Chemotherapy for intracranial ependymoma in adults (2016) Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, Westphal M, et al. Journal article Conventions and nomenclature for double diffusion encoding NMR and MRI (2016) Shemesh N, Jespersen SN, Alexander DC, Cohen Y, Drobnjak I, Dyrby TB, Finsterbusch J, et al. Journal article, Review article Dendritic self-avoidance (2016) Soba P Authored book Beratung zu körperlicher und sportlicher Aktivität in neurologischen Praxen in Deutschland. Ergebnisse einer Umfrage unter den Mitgliedern der Deutschen Gesellschaft für Neurologie e.V. (2016) Reimers CD, Reuter I, Straube A, Tettenborn B, Braumann KM, Reimers AK Journal article, Original article Using reciprocity for relating the simulation of transcranial current stimulation to the EEG forward problem (2016) Wagner S, Lucka F, Vorwerk J, Herrmann CS, Nolte G, Burger M, Wolters CH Journal article Factors Predicting Discordance in HER2 Phenotype between Primary Tumor and Circulating Tumor Cells in Women with Metastatic Breast Cancer (2016) Janni W, Schramm A, Friedl TWP, Schochter E, Huober J, Rack B, Alunni-Fabbroni M, et al. Conference contribution The DETECT Study Concept - Metastatic breast cancer and circulating tumor cells (2016) Schramm A, Friedl T, Rack B, Trapp E, Fasching P, Taran FA, Hartkopf A, et al. Conference contribution TREAT CTC: An innovative therapy approach to eliminate circulating tumor cells (CTCs) (2016) Tzschaschel M, Trapp E, Rack B, Messina C, Mueller V, Fehm T, Janni W, et al. Conference contribution Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial (2016) Janning M, Mueller , Vettorazzi E, Cubas-Cordova M, Gensch , Ben Batalla , Eulenburg ZC, et al. Conference contribution Multivariate diagnostic approaches in Frontotemporal lobar degeneration - Data from the german FTLDc (2016) Straub S, Schroeter ML, Diehl-Schmid J, Danek A, Von Arnim C, Bertram L, Einsiedler B, et al. Conference contribution